1. CMU Intellectual Repository

Browsing by Author Mark Mirochnick

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 15 to 30 of 30 < previous 
Issue DateTitleAuthor(s)
1-May-2013Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancyRegis Kreitchmann; Brookie M. Best; Jiajia Wang; Alice Stek; Edmund Caparelli; D. Heather Watts; Elizabeth Smith; David E. Shapiro; Steve Rossi; Sandra K. Burchett; Elizabeth Hawkins; Mark Byroads; Tim R. Cressey; Mark Mirochnick
1-Mar-2022Pharmacokinetics of Atazanavir Boosted with Cobicistat in Pregnant and Postpartum Women with HIVJeremiah D. Momper; Jiajia Wang; Alice Stek; David E. Shapiro; Kathleen M. Powis; Mary E. Paul; Martina L. Badell; Renee Browning; Nahida Chakhtoura; Kayla Denson; Kittipong Rungruengthanakit; Kathleen George; Edmund V. Capparelli; Mark Mirochnick; Brookie M. Best
1-Jul-2021Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIVJeremiah D. Momper; Jiajia Wang; Alice Stek; David E. Shapiro; Gwendolyn B. Scott; Mary E. Paul; Irma L. Febo; Sandra Burchett; Elizabeth Smith; Nahida Chakhtoura; Kayla Denson; Kittipong Rungruengthanakit; Kathleen George; Derek Z. Yang; Edmund V. Capparelli; Mark Mirochnick; Brookie M. Best
1-Jan-2015Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected womenAlice Stek; Brookie M. Best; Jiajia Wang; Edmund V. Capparelli; Sandra K. Burchett; Regis Kreitchmann; Kittipong Rungruengthanakit; Tim R. Cressey; Lynne M. Mofenson; Elizabeth Smith; David Shapiro; Mark Mirochnick
1-Jul-2016Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant WomenAnna H. Tran; Brookie M. Best; Alice Stek; Jiajia Wang; Edmund V. Capparelli; Sandra K. Burchett; Regis Kreitchmann; Kittipong Rungruengthanakit; Kathleen George; Tim R. Cressey; Nahida Chakhtoura; Elizabeth Smith; David E. Shapiro; Mark Mirochnick; Shelley Buschur; Chivon Jackson; Mary Paul; Donna McGregor; Ram Yogev; Rohit Kalra; Claudia Florez; Patricia Bryan; Monica Stone; Andrew D. Hull; Mary Caffery; Stephen A. Spector; Joan Wilson; Julieta Giner; Margaret A. Donnelly; Ellen R. Cooper; Debra A. McLaud; Lisa F. Tucker; Jane Hitti; Amanda Robson-Nuss; Ann J. Melvin; Margaret A. Keller; Michael A. Bolaris; Judy Hayes; Françoise Kamer; La Shonda Spencer; James Homans; Torri Metz; Jenna Wallace; Alisa Katai; Mariam Aziz; Maureen McNichols; Julie Schmidt; Diane Wara; Kristinalisa Maka; Deborah Cohan; Audra Deveikis; Jagmohan Batra; Janielle Jackson Alvarez; Michele Carter; Jaime Deville; Carla Janzen; Jenny Gutierrez; Martha Cavallo; Murli Purswani; Katherine M. Knapp; Nina Sublette; Thomas Wride
1-Mar-2021Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIVKristina M. Brooks; Jeremiah D. Momper; Mauricio Pinilla; Alice M. Stek; Emily Barr; Adriana Weinberg; Jaime G. Deville; Irma L. Febo; Mikhaela Cielo; Kathleen George; Kayla Denson; Kittipong Rungruengthanakit; David E. Shapiro; Elizabeth Smith; Nahida Chakhtoura; James F. Rooney; Richard Haubrich; Rowena Espina; Edmund V. Capparelli; Mark Mirochnick; Brookie M. Best
1-Jul-2022Pharmacokinetics of Tenofovir Alafenamide with Boosted Protease Inhibitors in Pregnant and Postpartum Women Living with HIV: Results from IMPAACT P1026sKristina M. Brooks; Mauricio Pinilla; Alice M. Stek; David E. Shapiro; Emily Barr; Irma L. Febo; Mary E. Paul; Jaime G. Deville; Kathleen George; Kevin Knowles; Kittipong Rungruengthanakit; Renee Browning; Nahida Chakhtoura; Edmund V. Capparelli; Mark Mirochnick; Brookie M. Best
1-Feb-2018A phase II/III trial of lopinavir/ritonavir dosed according to the WHO pediatric weight band dosing guidelinesJorge A. Pinto; Edmund V. Capparelli; Meredith Warshaw; Bonnie Zimmer; Tim R. Cressey; Stephen A. Spector; Min Qin; Betsy Smith; George K. Siberry; Mark Mirochnick
1-Jun-2021Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and RaltegravirXiaomei I. Liu; Jeremiah D. Momper; Natella Y. Rakhmanina; Dionna J. Green; Gilbert J. Burckart; Tim R. Cressey; Mark Mirochnick; Brookie M. Best; John N. van den Anker; André Dallmann
1-Mar-2021Population pharmacokinetics of tenofovir in pregnant and postpartum women using tenofovir disoproxil fumarateAhizechukwu C. Eke; Kensuke Shoji; Brookie M. Best; Jeremiah D. Momper; Alice M. Stek; Tim R. Cressey; Mark Mirochnick; Edmund V. Capparelli
1-Jan-2020Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic ModelingXiaomei I. Liu; Jeremiah D. Momper; Natella Y. Rakhmanina; Dionna J. Green; Gilbert J. Burckart; Tim R. Cressey; Mark Mirochnick; Brookie M. Best; John N. van den Anker; André Dallmann
2-Jan-2018Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerationsDiana F. Clarke; Martina Penazzato; Edmund Capparelli; Tim R. Cressey; George Siberry; Nandita Sugandhi; Mark Mirochnick
1-Jan-2014Raltegravir pharmacokinetics during pregnancyD. Heather Watts; Alice Stek; Brookie M. Best; Jiajia Wang; Edmund V. Capparelli; Tim R. Cressey; Francesca Aweeka; Patty Lizak; Regis Kreitchmann; Sandra K. Burchett; David E. Shapiro; Elizabeth Hawkins; Elizabeth Smith; Mark Mirochnick
1-May-2020Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trialEsaú C. João; R. Leavitt Morrison; David E. Shapiro; Nahida Chakhtoura; Maria Isabel S. Gouvèa; Maria de Lourdes B Teixeira; Trevon L. Fuller; Blandina T. Mmbaga; James S. Ngocho; Boniface N. Njau; Avy Violari; Ruth Mathiba; Zaynab Essack; Jose Henrique S. Pilotto; Luis Felipe Moreira; Maria Jose Rolon; Pedro Cahn; Sinart Prommas; Timothy R. Cressey; Kulkanya Chokephaibulkit; Peerawong Werarak; Lauren Laimon; Roslyn Hennessy; Lisa M. Frenkel; Patricia Anthony; Brookie M. Best; George K. Siberry; Mark Mirochnick
1-Sep-2013Reduced indinavir exposure during pregnancyTim R. Cressey; Brookie M. Best; Jullapong Achalapong; Alice Stek; Jiajia Wang; Nantasak Chotivanich; Prapap Yuthavisuthi; Pornnapa Suriyachai; Sinart Prommas; David E. Shapiro; D. Heather Watts; Elizabeth Smith; Edmund Capparelli; Regis Kreitchmann; Mark Mirochnick
1-Sep-2022What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studiesTom G. Jacobs; Stef Schouwenburg; Martina Penazzato; Moherndran Archary; Theodore D. Ruel; John van den Anker; David M. Burger; Tim R. Cressey; Elaine J. Abrams; Hermione Lyall; Adrie Bekker; Angela Colbers; David Burger; Tim Cressey; Deborah Hirt; Irja Lutsar; Helen Mcilleron; Joe Standing; Elin Svensson; Elaine Abrams; Pauline Amuge; Mo Archary; Yodit Belew; Brookie Best; Helen Bygrave; Edmund Capparelli; Esther Casas; Diana Clarke; Polly Clayden; Mutsa Dangarembizi; Roberto De Lisa; Paolo Denti; Paul Domanico; Shaffiq Essajee; Lisa Frigati; Carlo Giaquinto; Diana Gibb; Stephanie Hackett; Rohan Hazra; Marc Lallemant; Linda Lewis; Shahin Lockman; Imelda Mahaka; Betsy McFarland; Cathal Meere; Fatima Mir; Mark Mirochnick; Lynne Mofenson; Irene Mukui; Angela Mushavi; Victor Musiime; Eleanor Namusoke-Magongo; Elisabeth Obimbo; Mary Atieno Ojoo; Roger Parades; Carmen Perez-Casas; Manuele Piccolis; Jorge Pinto; Thanyawee Puthanakit; Natella Rakhmanina; Annette Reinisch; Pablo Rojo; Vanessa Rouzier; Ted Ruel; Nadia Sam-Agudu; George Siberry; Teresa Simione; Katie Simon; Vindi Singh; Manjari Solares; Nandita Sugandhi; Mariam Sylla; Ibou Thior; Anna Turkova; Marissa Vicari; Jenny Walsh; Melynda Watkins; Hilary Wolf; Asma Hafiz; Ajay Rangaraj; Meg Doherty; Marco Vitoria
Showing results 15 to 30 of 30 < previous